Pfizer moves forward with weight loss pill
Pfizer plans to move a reworked, once-daily version of its danuglipron weight-loss pill into clinical trials later this year, after scrapping a twice-daily version of the drug late last year.
BELIEBTE BEITRÄGE
UK sets new climate target for 2035
November 13, 2024
Children go back to school after Valencia floods
November 13, 2024
Researchers document huge decline in African elephants
November 13, 2024
Mission: Impossible 8 title revealed
November 13, 2024
LIVEÜBERTRAGUNG